- Home
- MYGN vs SCVL Comparison
MYGN vs SCVL Comparison
Compare MYGN & SCVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- SCVL
- Stock Information
- Founded
- MYGN 1991
- SCVL 1978
- Country
- MYGN United States
- SCVL United States
- Employees
- MYGN N/A
- SCVL N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SCVL Clothing/Shoe/Accessory Stores
- Sector
- MYGN Health Care
- SCVL Consumer Discretionary
- Exchange
- MYGN Nasdaq
- SCVL Nasdaq
- Market Cap
- MYGN 642.0M
- SCVL 547.9M
- IPO Year
- MYGN 1995
- SCVL 1993
- Fundamental
- Price
- MYGN $7.40
- SCVL $23.19
- Analyst Decision
- MYGN Hold
- SCVL Hold
- Analyst Count
- MYGN 13
- SCVL 1
- Target Price
- MYGN $13.50
- SCVL N/A
- AVG Volume (30 Days)
- MYGN 1.3M
- SCVL 519.8K
- Earning Date
- MYGN 11-06-2025
- SCVL 09-04-2025
- Dividend Yield
- MYGN N/A
- SCVL 2.58%
- EPS Growth
- MYGN N/A
- SCVL N/A
- EPS
- MYGN N/A
- SCVL 2.27
- Revenue
- MYGN $832,900,000.00
- SCVL $1,153,927,000.00
- Revenue This Year
- MYGN $0.17
- SCVL N/A
- Revenue Next Year
- MYGN $6.19
- SCVL $2.07
- P/E Ratio
- MYGN N/A
- SCVL $10.23
- Revenue Growth
- MYGN 3.83
- SCVL N/A
- 52 Week Low
- MYGN $3.76
- SCVL $16.14
- 52 Week High
- MYGN $29.30
- SCVL $46.92
- Technical
- Relative Strength Index (RSI)
- MYGN 66.01
- SCVL 54.40
- Support Level
- MYGN $7.13
- SCVL $22.76
- Resistance Level
- MYGN $7.80
- SCVL $24.21
- Average True Range (ATR)
- MYGN 0.44
- SCVL 1.01
- MACD
- MYGN 0.04
- SCVL -0.02
- Stochastic Oscillator
- MYGN 78.61
- SCVL 43.29
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About SCVL Shoe Carnival Inc.
Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.